Valeritas Holdings, Inc.

VLRXQ

US91914N3017

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-4.76%	-96.52%

2020	Valeritas Holdings, Inc. Went Out of Business	CI
2020	First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	CI

Valeritas Holdings, Inc. Provides Revenue Guidance for the First Quarter of 2019

May 02, 2019 at 07:00 am EDT

Valeritas Holdings, Inc. provided revenue guidance for the first quarter of 2019. For the quarter, the company expects revenue of approximately $6.4 million.

Latest news about Valeritas Holdings, Inc.

Valeritas Holdings, Inc. Went Out of Business	20-06-30	CI
First Amended Combined Joint Liquidation Plan & Disclosure Statement Approved for Valeritas Holdings, Inc.	20-06-08	CI
First Motion for Exclusivity Period Extension Approved For Valeritas Holdings, Inc.	20-06-03	CI
First Motion for Exclusivity Period Extension Filed by Valeritas Holdings, Inc.	20-05-21	CI
Combined Disclosure Statement and Liquidation Plan Approved for Solicitation Purpose on Interim Basis for Valeritas Holdings, Inc.	20-04-21	CI
First Amended Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	20-04-15	CI
Combined Joint Liquidation Plan & Disclosure Statement Filed by Valeritas Holdings, Inc.	20-04-06	CI
Valeritas Holdings, Inc. Announces Management Changes	20-04-02	CI
Zealand Pharma A/S completed the acquisition of substantially all assets of Valeritas Holdings, Inc.	20-04-01	CI
Motion for Asset Sale Approved for Valeritas Holdings, Inc.	20-03-20	CI
Final DIP Financing Approved for Valeritas Holdings, Inc.	20-03-13	CI
Notice for Auction Cancellation Filed by Valeritas Holdings, Inc.	20-03-13	CI
Bidding Procedure Approved for Valeritas Holdings, Inc.	20-03-06	CI
Valeritas Holdings, Inc. Terminates Joseph Saldanha as Chief Business Officer, Effective from March 6, 2020	20-02-28	CI
Valeritas Holdings, Inc.(OTCPK:VLRX.Q) dropped from NASDAQ Composite Index	20-02-19	CI
The United States Bankruptcy Court for the District of Delaware Enters an Order Granting an Interim Approval to Valeritas Holdings, Inc.'s Proposed Senior Secured Priming Debtor-In-Possession Financing Facility	20-02-14	CI
Interim DIP Financing Approved for Valeritas Holdings, Inc.	20-02-14	CI
Asset Purchase Agreement Filed by Valeritas Holdings, Inc.	20-02-14	CI
Valeritas Holdings, Inc.(NasdaqCM:VLRX) dropped from S&P TMI Index	20-02-12	CI
Motion for Joint Administration Approved for Valeritas Holdings, Inc.	20-02-11	CI
Motion for Asset Sale Filed by Valeritas Holdings, Inc.	20-02-10	CI
Valeritas Holdings, Inc. Filed for Bankruptcy	20-02-09	CI
Motion for Joint Administration Filed by Valeritas Holdings, Inc.	20-02-08	CI
Zealand Pharma A/S entered into a stalking horse agreement to acquire substantially all assets of Valeritas Holdings, Inc.	20-02-08	CI
Valeritas Holdings, Inc. Announces Appointment of Melanie Hansen as Treasurer and Principal Accounting Officer, Effective January 13, 2020	20-01-10	CI

Chart Valeritas Holdings, Inc.

Duration

Period

More charts

Valeritas Holdings, Inc. is a United States-based medical technology company. The Company's product, V-Go Wearable Insulin Delivery device (V-Go), is a wearable, basal-bolus insulin delivery device for adult patients requiring insulin that enables patients to administer a continuous preset basal rate of insulin over 24 hours. V-Go is a small wearable and completely disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body's normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. It has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VALERITAS HOLDINGS, INC.	-96.52%	167K
ABBOTT LABORATORIES	-4.98%	182B
MEDTRONIC PLC	+2.84%	112B
BECTON, DICKINSON AND COMPANY	-2.68%	68.58B
DEXCOM, INC.	+4.53%	51.58B
CENCORA, INC.	+8.00%	44.24B
HOYA CORPORATION	+9.65%	43.65B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.30%	32.46B
WEST PHARMACEUTICAL SERVICES, INC.	-0.17%	25.61B
TERUMO CORPORATION	+21.57%	25.99B

Other Medical Equipment, Supplies & Distribution